Hard Gelatin Capsules Market By Source Type (Type B Gelatin (Bovine Source), Type A Gelatin (Porcine Source), Fish (Marine) Gelatin, Other Gelatin Sources); By Application (Pharmaceutical Applications, Nutraceutical Applications, Cosmetics & Other Applications); By Technology (Conventional Two-Piece Capsule Technology, Advanced Capsule Technologies); By End-Use Industry (Pharmaceutical Companies and CDMOs, Nutraceutical Manufacturers, Hospitals, Clinics, and Compounding Facilities); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Hard Gelatin Capsules Anchor High-Volume Oral Medicine Production – (Updated On: 28th-Sep-2026)

The Global Hard Gelatin Capsules Market was valued at USD 3.15 billion in 2025 and is projected to reach USD 4.60 billion by 2032, expanding at a CAGR of 5.55% during 2026–2032, according to Strategic Market Research.

 

Hard gelatin capsules are two-piece empty gelatin capsule shells used for filling pharmaceutical drugs, nutraceuticals, and herbal formulations. These capsules consist of a gelatin-based body and cap, produced mainly from collagen-derived gelatin obtained from bovine or porcine sources.

 

More than 740 billion hard capsule units are estimated to be consumed annually worldwide, with gelatin capsules accounting for approximately 80–85% of total hard capsule demand, translating into nearly 600 billion gelatin capsule shells annually. The United States alone consumes over 145 billion hard capsules every year, supported by high prescription drug consumption and strong dietary supplement adoption.

 

Manufacturing leadership is concentrated among companies such as Lonza (Capsugel), ACG Worldwide, Qualicaps, Suheung, and CapsCanada, which supply empty capsule shells to pharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and supplement producers worldwide. India, China, and Vietnam have emerged as major production and export hubs supported by large-scale manufacturing capacity, competitive production economics, and strong pharmaceutical supply chains. Market opportunities are further expanding through advancements in liquid-filled hard capsules, improved capsule-locking technologies, customized colors and imprinting solutions, and specialized capsule designs for modified-release formulations.

 

Overall, Hard gelatin capsules remain a high-volume component of oral solid dosage manufacturing, with pharmaceutical companies relying on standardized capsule shells for rapid formulation development, cost-efficient production, and flexible dosing across prescription, OTC, and nutraceutical products."

 

Bovine Gelatin Sets the Revenue Base as Marine Sources Accelerate

Source Type: Bovine Gelatin Leads While Marine Gelatin Gains Strategic Growth

Leading Segment: Type B Gelatin (Bovine Source)

Type B Gelatin (Bovine Source) holds the leading position in the hard gelatin capsules market, accounting for a 46% market share in 2025 with revenue of USD 1.45 billion and projected to grow at a CAGR of 5.85% during 2026–2032. Derived from bovine collagen through alkaline processing, Type B gelatin serves as the primary shell-forming material for hard capsules, offering the required combination of mechanical strength, flexibility, thermal stability, and dissolution performance. Its high Bloom strength enables durable capsule shells capable of withstanding high-speed filling, transportation, and storage conditions, while its sol-to-gel transition properties support consistent manufacturing quality. The material’s rapid dissolution in gastrointestinal fluids and established pharmaceutical compatibility continue to support its widespread adoption for encapsulating powders, granules, and pellets across pharmaceutical and nutraceutical applications.

Fastest-Growing Segment: Fish (Marine) Gelatin

Market Share (2025): 12% | Revenue: USD 0.38 Billion | CAGR (2026–2032): 6.65%

Fish-derived gelatin, extracted from marine sources such as fish skin, bones, and scales, holds a 12% share of the hard gelatin capsules market in 2025, generating USD 0.38 billion in revenue, and is projected to expand at a CAGR of 6.65% during 2026–2032. It is increasingly preferred as a sustainable and dietary-friendly alternative to bovine and porcine gelatin for pharmaceutical and nutraceutical capsule shells. Marine gelatin provides the required mechanical strength, flexibility, and dissolution performance for hard capsule manufacturing while supporting Halal and Kosher-compliant formulations. Its utilization of fish-processing by-products enhances raw material efficiency, while its biodegradability, rapid disintegration characteristics, and thermoreversible gel-forming properties strengthen its adoption in next-generation hard capsule applications.

 

Application: Pharmaceuticals Dominate While Nutraceuticals Drive Premium Growth

Leading Segment: Pharmaceutical Applications

Pharmaceutical applications dominate the hard gelatin capsules market, accounting for 72% share in 2025 with revenue of USD 2.27 billion. Hard gelatin capsules are extensively used as a preferred oral dosage format for encapsulating active pharmaceutical ingredients (APIs), powders, granules, pellets, and specialized drug formulations due to their rapid dissolution, dosing flexibility, and compatibility with diverse therapeutic compounds. They serve as a key delivery platform for conventional oral medicines, where capsules typically dissolve within 20–30 minutes to release the drug payload. Pharmaceutical companies also rely on hard gelatin capsules for Phase I and Phase II clinical trials, drug-in-capsule prototypes, blinded comparator studies, and placebo matching due to their customization flexibility. In addition, they support advanced drug delivery approaches such as modified-release pellets, coated granules, and multiparticulate systems, while improving patient acceptance by masking unpleasant tastes and odors of certain APIs.

Fastest-Growing Segment: Nutraceutical Applications

Nutraceutical Application segment accounts for 25% of the hard gelatin capsules market in 2025, generating USD 0.79 billion in revenue, and is projected to expand at a CAGR of 6.55% during 2026–2032. Hard gelatin capsules represent a widely adopted dosage format in the nutraceutical sector, enabling efficient delivery of vitamins, minerals, herbal extracts, probiotics, and other bioactive ingredients. Their neutral taste, easy swallowing characteristics, rapid dissolution profile, and compatibility with powders, granules, and pellets make them a preferred choice for supplement manufacturers. These capsules support ingredient protection, accurate dosing, and flexible formulation designs, helping brands develop convenient and consumer-friendly nutraceutical products.

 

Technology: Conventional Manufacturing Leads While Advanced Capsule Systems Expand

Leading Segment: Conventional Two-Piece Capsule Technology

Conventional two-piece capsule technology remains the dominant format in the hard gelatin capsules market, accounting for 82% share with USD 2.58 billion revenue in 2025. These capsules are manufactured through precision pin-dipping, where a pre-formed cylindrical body and matching cap are joined to create a reliable oral dosage delivery system. The technology supports pharmaceutical and nutraceutical formulations including powders, granules, pellets, and non-aqueous liquids while enabling high-speed automated filling operations. Rapid dissolution, effective taste masking, and protection of sensitive active ingredients continue to support its widespread adoption, although moisture sensitivity and gelatin cross-linking risks require controlled formulation conditions. The segment is projected to grow at a CAGR of 5.15% during 2026–2032.

Fastest-Growing Segment: Advanced Capsule Technologies

Advanced Capsule Technologies segment accounted for 18% of the Hard Gelatin Capsules Market in 2025, generating USD 0.57 billion in revenue, and is projected to expand at a CAGR of 7.45% during 2026–2032. These technologies are reshaping the market by upgrading conventional hard gelatin capsules into advanced drug delivery platforms capable of controlled release, improved stability, and targeted therapeutic performance. Innovations such as multilayer shells, enteric-ready capsules, precision manufacturing, and specialized filling systems are enabling pharmaceutical companies to develop complex formulations while improving dosing flexibility and patient compliance. Technologies including capsule-in-capsule designs, liquid-filled hard gelatin capsules, and smart filling systems are expanding the application scope of hard gelatin capsules across combination therapies and specialized drug delivery solutions.

 

End-Use Industry: Pharmaceutical Companies Remain the Largest Buyers

Leading Segment: Pharmaceutical Companies & CDMOs

Pharmaceutical companies and capsule CDMOs represent the largest contributor to the Hard Gelatin Capsules Market, supporting the development, manufacturing, and commercialization of capsule-based drug formulations. These companies rely on CDMOs for specialized capsule filling capabilities, scalable production, and regulatory-compliant manufacturing, while retaining control over drug formulation, branding, and market strategy. Together, they generated USD 2.14 billion in 2025 revenue, accounting for a 68% market share, and are projected to expand at a 5.60% CAGR through 2032.

Fastest-Growing Segment: Nutraceutical Manufacturers

Nutraceutical manufacturers accounted for 27% of the Hard Gelatin Capsules Market in 2025, generating USD 0.85 billion in revenue, and are projected to expand at a CAGR of 6.40% during 2026–2032. This segment represents a major end-user group, utilizing hard gelatin capsules for delivering vitamins, probiotics, minerals, and herbal supplements with improved stability, accurate dosing, and enhanced consumer convenience. Growing production of dietary supplements, customized formulations, and demand for easy-to-consume wellness products continue to strengthen the adoption of hard gelatin capsules across nutraceutical applications.

 

Geography: Asia-Pacific Leads Future Expansion

Leading Segment: North America

North America holds a leading position in the Hard Gelatin Capsules Market, accounting for 34% of global revenue in 2025, equivalent to USD 1.07 billion. Regional demand is supported by high consumption of empty hard gelatin capsules across pharmaceutical and nutraceutical manufacturing, particularly for prescription drugs, vitamins, dietary supplements, and combination formulations. Expansion of capsule-filling operations, contract pharmaceutical manufacturing, and demand for flexible solid oral dosage formats are strengthening capsule consumption. Continued product development across pharmaceutical and nutraceutical applications is expected to support a 5.10% CAGR during 2026–2032.

Fastest-Growing Segment: Asia-Pacific

Asia-Pacific Hard Gelatin Capsules Market accounted for 30% of the global market in 2025, generating USD 0.95 billion in revenue, and is projected to expand at a CAGR of 7.25% during 2026–2032. The region is emerging as a major manufacturing and consumption hub for empty hard gelatin capsules, supported by expanding generic drug production, increasing capsule-filling capacity, and rising use of capsule-based formulations across pharmaceutical and nutraceutical applications. Investments by capsule manufacturers, contract pharmaceutical producers, and drug companies are further expanding regional production capacity and strengthening the hard gelatin capsule supply base.

 

Medicine Output and Supplement Demand Lift Capsule Consumption

Rising Pharmaceutical Production and Expansion of Oral Solid Dosage Medicines

The growing global pharmaceutical manufacturing base remains the primary demand driver for hard gelatin capsules. Capsules continue to be widely preferred for generic drugs, prescription medicines, and over-the-counter formulations due to their rapid dissolution, accurate dosing capability, and compatibility with powders, granules, and pellets. Global pharmaceutical sales exceeded USD 1.6 trillion in 2023, supported by increasing medicine consumption, expanding chronic disease treatment, and rising healthcare access across emerging economies. As pharmaceutical companies and CDMOs increase production capacity, demand for empty hard gelatin shells continues to rise as a critical component of oral drug manufacturing.

 

Growing Burden of Chronic Diseases Increasing Capsule-Based Medication Demand

The rising prevalence of chronic conditions such as cardiovascular diseases, diabetes, respiratory disorders, and neurological diseases is increasing long-term medication consumption globally. According to the World Health Organization (WHO), noncommunicable diseases account for nearly 74% of global deaths annually, creating sustained demand for continuous medication therapies. Hard gelatin capsules are extensively used in chronic disease medicines because they support efficient formulation of APIs requiring improved taste masking, patient convenience, and reliable dosage delivery.

 

Expansion of Nutraceutical and Preventive Healthcare Markets

Increasing consumer focus on preventive healthcare is accelerating the adoption of capsule-based dietary supplements. Vitamins, minerals, probiotics, herbal extracts, collagen supplements, and sports nutrition products are increasingly manufactured in capsule formats due to their convenience, premium appearance, and ability to protect sensitive ingredients. The global dietary supplements industry has experienced strong growth as consumers shift toward daily wellness products, creating a significant secondary demand stream for hard gelatin capsule manufacturers beyond traditional pharmaceuticals.

 

Aging Population Driving Higher Medication Consumption

Demographic aging is creating long-term growth opportunities for capsule manufacturers as elderly populations require greater use of prescription medicines and nutritional supplements. According to the United Nations, the global population aged 65 years and above is projected to increase from around 761 million in 2021 to 1.6 billion by 2050. Older populations typically have higher rates of chronic disease management and polypharmacy, increasing consumption of convenient oral dosage forms such as hard gelatin capsules.

 

Increasing Generic Drug Manufacturing and CDMO Outsourcing

The expansion of generic medicines and pharmaceutical outsourcing is strengthening demand for empty capsule shells. Pharmaceutical companies are increasingly partnering with contract development and manufacturing organizations (CDMOs) to improve production efficiency and reduce manufacturing costs. Countries including India and China have become major pharmaceutical production hubs, supporting large-scale capsule consumption through extensive generic drug manufacturing and export activities.

 

Technological Advancements Improving Capsule Applications

Innovation in capsule manufacturing is expanding the use cases of hard gelatin capsules beyond conventional powder filling. Developments such as liquid-filled hard capsules, modified-release capsules, improved sealing systems, and customized capsule designs are enabling pharmaceutical companies to formulate complex drug molecules with enhanced stability and delivery characteristics. These advancements are increasing adoption among companies developing specialty medicines and high-value formulations.

 

Global Capsule Suppliers Compete on Scale and Specialized Formats

Lonza (Capsugel) – Global Benchmark in Hard Gelatin Capsule Manufacturing

Lonza’s Capsugel business has historically been one of the most influential players in the global hard gelatin capsules market, with a strong presence across pharmaceutical, nutraceutical, and consumer healthcare industries. Capsugel developed widely adopted capsule platforms such as Coni-Snap® hard gelatin capsules, which are designed for high-speed filling operations and used by pharmaceutical companies worldwide. The company has operated manufacturing facilities across major pharmaceutical regions, including North America, Europe, and Asia, supporting global supply chains for empty hard capsule shells.

Capsugel’s competitive advantage has been built around large-scale production capability, extensive capsule portfolio, and close integration with pharmaceutical manufacturers and CDMOs. Its product range includes conventional hard gelatin capsules along with specialized formats such as liquid-filled capsules and vegetarian capsule technologies. The company’s Coni-Snap® design incorporates features such as capsule locking systems and air-venting mechanisms to improve compatibility with automated filling equipment, making it suitable for high-volume pharmaceutical production.

Lonza completed the acquisition of Capsugel in 2017 for approximately USD 5.5 billion, strengthening its position as an integrated supplier for pharmaceutical and healthcare manufacturers. However, Lonza later announced plans to separate its capsules and health ingredients business to focus on its core CDMO operations, with the capsule business being positioned for ownership transition. Despite this strategic shift, Capsugel remains recognized as one of the most established global capsule brands with decades of manufacturing expertise.

Regional Producers Expand the Capsule Supply Field

• ACG Worldwide – One of the largest global suppliers of empty hard capsules, supporting pharmaceutical and nutraceutical manufacturers through large-scale capsule production facilities across India and international markets.

• Qualicaps Co., Ltd. – Focuses on high-quality hard gelatin and vegetarian capsules, supplying pharmaceutical companies with precision-manufactured capsule shells and customized solutions.

• Suheung Co., Ltd. – A major South Korean capsule manufacturer serving global pharmaceutical and supplement markets with high-volume gelatin capsule production and export capabilities.

• CapsCanada Corporation – Provides hard gelatin and vegetarian capsule solutions primarily for pharmaceutical and nutraceutical manufacturers in North America and international markets.

• Qingdao Yiqing Medicinal Capsules Co., Ltd. – A significant Chinese capsule producer supplying large-volume empty capsule requirements for domestic and international pharmaceutical companies.

• Sunil Healthcare Ltd. – An Indian capsule manufacturer specializing in hard gelatin and vegetarian capsules, supporting pharmaceutical exporters and domestic drug manufacturers.

• Natural Capsules Limited – Provides empty hard gelatin and HPMC capsules for pharmaceutical, nutraceutical, and healthcare applications with manufacturing operations focused on global supply.

• Lefancaps International – Supplies specialized capsule formats and empty hard capsule shells for pharmaceutical and dietary supplement applications.

 

Analyst View: Scale and Specialized Formats Shape the Next Phase

The hard gelatin capsules market continues to be shaped by rising pharmaceutical production, expanding nutraceutical consumption, and the growing need for efficient oral drug delivery formats. While conventional gelatin capsules remain dominant due to cost efficiency, manufacturing maturity, and broad regulatory acceptance, demand is gradually moving toward specialized solutions such as customized capsules, liquid-filled formats, and alternative gelatin sources. Manufacturers with strong global production networks, advanced capsule technologies, and capabilities to support pharmaceutical and supplement brands are positioned to capture emerging opportunities across the evolving capsule delivery landscape.

 

Hard Gelatin Capsules Market Report Coverage at a Glance

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 3.15 Billion
Revenue Forecast in 2032	USD 4.60 Billion
Overall Growth Rate	CAGR of 5.55% (2026–2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Billion, CAGR (2026–2032)
Segmentation	By Source Type, By Application, By Technology, By End-Use Industry, By Geography
By Source Type	Type B Gelatin (Bovine Source), Type A Gelatin (Porcine Source), Fish (Marine) Gelatin, Other Gelatin Sources
By Application	Pharmaceutical Applications, Nutraceutical Applications, Cosmetics & Other Applications
By Technology	Conventional Two-Piece Capsule Technology, Advanced Capsule Technologies
By End-Use Industry	Pharmaceutical Companies and CDMOs, Nutraceutical Manufacturers, Hospitals, Clinics, and Compounding Facilities
By Geography	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, Germany, France, Netherlands, China, India, South Korea, Japan, Brazil, Mexico, UAE, Saudi Arabia, South Africa
Market Drivers	rising pharmaceutical production, expanding nutraceutical consumption, and the growing need for efficient oral drug delivery formats
Customization Option	Available upon request